trial
as of 2026-07-01Donepezil Double Blind Trial for ECT Memory Disfunction
NCTId NCT00465283
at a glance
Phase 4 · Unknown
Enrollment 40 (estimated)
Sponsored by BeerYaakov Mental Health Center
Primary completion 2010-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2007-05
Primary completion
2010-01
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
BeerYaakov Mental Health CenterLead Sponsor
Investigators
1
Tali Nachshoni, MDPrincipal Investigator
Sites
1 total
Beer Yaacov, Israel
Facts & assertions
4 sourced
Enrollment
40
Phase
PHASE4
Primary Completion Date
2010-01
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person